Skip to main content
TipRanks
Go Ultimate75% OFF

PT Kalbe Farma Tbk (PTKFY) Stock Statistics & Valuation Metrics

7 Followers

Total Valuation

PT Kalbe Farma Tbk has a market cap or net worth of $2.03B. The enterprise value is $1.63B.

Market Cap
$2.03B
Enterprise Value
$1.63B

Share Statistics

PT Kalbe Farma Tbk has 234,066,960 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
234,066,960
Owned by Insiders
―
Owned by Institutions
0.03%

Financial Efficiency

PT Kalbe Farma Tbk’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 13.97%.

Return on Equity (ROE)
0.16
Return on Assets (ROA)
0.12
Return on Invested Capital (ROIC)
13.97%
Return on Capital Employed (ROCE)
0.18
Revenue Per Employee
2.75B
Profits Per Employee
285.55M
Employee Count
12,835
Asset Turnover
1.15
Inventory Turnover
3.04

Valuation Ratios

The current PE Ratio of PT Kalbe Farma Tbk is 9.49. PT Kalbe Farma Tbk’s PEG ratio is 1.11.

PE Ratio
9.49
PS Ratio
0.93
PB Ratio
1.42
Price to FCF
12.08
Price to Operating Cash Flow
9.34
PEG Ratio
1.11

Income Statement

In the last 12 months, PT Kalbe Farma Tbk had revenue of 35.32T and earned 3.66T in profits. Earnings per share was 16176.00.

Revenue
35.32T
Gross Profit
14.06T
Operating Income
4.55T
Pretax Income
4.78T
Net Income
3.66T
EBITDA
5.60T
Earnings Per Share (EPS)
16176.00

Cash Flow

In the last 12 months, operating cash flow was 3.88T and capital expenditures -874.56B, giving a free cash flow of 3.00T billion.

Operating Cash Flow
3.88T
Free Cash Flow
3.00T
Free Cash Flow per Share
13078.88

Dividends & Yields

PT Kalbe Farma Tbk pays an annual dividend of $0.22, resulting in a dividend yield of 2.31%

Dividend Per Share
$0.22
Dividend Yield
2.31%
Payout Ratio
23.13%
Free Cash Flow Yield
8.28%
Earnings Yield
10.56%

Stock Price Statistics

Beta
0.60
52-Week Price Change
-40.88%
50-Day Moving Average
8.28
200-Day Moving Average
9.44
Relative Strength Index (RSI)
59.48
Average Volume (3m)
15.31K

Important Dates

PT Kalbe Farma Tbk upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 30, 2026
Next Earnings Date
Apr 01, 2027
Ex-Dividend Date
Jun 05, 2026

Financial Position

PT Kalbe Farma Tbk as a current ratio of 3.47, with Debt / Equity ratio of 1.28%

Current Ratio
3.47
Quick Ratio
2.16
Debt to Market Cap
0.00
Net Debt to EBITDA
-0.72
Interest Coverage Ratio
128.95

Taxes

In the past 12 months, PT Kalbe Farma Tbk has paid 1.03T in taxes.

Income Tax
1.03T
Effective Tax Rate
0.22

Enterprise Valuation

PT Kalbe Farma Tbk EV to EBITDA ratio is 5.53, with an EV/FCF ratio of 10.34.

EV to Sales
0.80
EV to EBITDA
5.53
EV to Free Cash Flow
10.34
EV to Operating Cash Flow
8.00

Balance Sheet

PT Kalbe Farma Tbk has $5.58T in cash and marketable securities with $295.23B in debt, giving a net cash position of $5.29T billion.

Cash & Marketable Securities
$5.58T
Total Debt
$295.23B
Net Cash
$5.29T
Net Cash Per Share
$22.59K
Tangible Book Value Per Share
$108.37K

Margins

Gross margin is 37.18%, with operating margin of 12.25%, and net profit margin of 9.84%.

Gross Margin
37.18%
Operating Margin
12.25%
Pretax Margin
12.91%
Net Profit Margin
9.84%
EBITDA Margin
14.42%
EBIT Margin
12.32%

Analyst Forecast

The average price target for PT Kalbe Farma Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
5.51%
EPS Growth Forecast
3.30%

Scores

Smart Score
3
AI Score
74